All Pharma News
Praxis At AAN On Ulixacaltamide

Praxis At AAN On Ulixacaltamide
GLOBENEWSWIRE
12 Apr 2024
Share Share
Praxis Precision Medicines to Participate in Upcoming April Conferences

Praxis Precision Medicines to Participate in Upcoming April Conferences
GLOBENEWSWIRE
05 Apr 2024
Share Share
Praxis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Praxis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GLOBENEWSWIRE
02 Apr 2024
Share Share
Praxis Precision Announces Pricing of $200 Million Public Offering

Praxis Precision Announces Pricing of $200 Million Public Offering
GLOBENEWSWIRE
28 Mar 2024
Share Share
Praxis Precision Medicines, Inc. Announces Proposed Public Offering

Praxis Precision Medicines, Inc. Announces Proposed Public Offering
GLOBENEWSWIRE
27 Mar 2024
Share Share
Praxis Positive Results of PRAX-628 Study Evaluating PPR Achieving 100% Response

Praxis Positive Results of PRAX-628 Study Evaluating PPR Achieving 100% Response
GLOBENEWSWIRE
26 Mar 2024
Share Share
Praxis’ epilepsy drug hits in phase 2, sparking stock rise

Praxis’ epilepsy drug hits in phase 2, sparking stock rise
Nick Paul Taylor FIERCE BIOTECH
26 Mar 2024
Share Share
Praxis Precision Medicines to Host PRAX-628 Program Update

Praxis Precision Medicines to Host PRAX-628 Program Update
GLOBENEWSWIRE
25 Mar 2024
Share Share
Praxis Precision Reports Fourth Quarter and Full-Year 2023 Financial Results

Praxis Precision Reports Fourth Quarter and Full-Year 2023 Financial Results
GLOBENEWSWIRE
05 Mar 2024
Share Share
Praxis Precision to Participate in TD Cowen™s 44th Annual Health Care Conference

Praxis Precision to Participate in TD Cowen™s 44th Annual Health Care Conference
GLOBENEWSWIRE
01 Mar 2024
Share Share